These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15339672)

  • 1. No increase in age-specific incidence of myelodysplastic syndromes.
    Germing U; Strupp C; Kündgen A; Bowen D; Aul C; Haas R; Gattermann N
    Haematologica; 2004 Aug; 89(8):905-10. PubMed ID: 15339672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolutive epidemiologic profile of myelodysplastic syndromes (1959-1993). Comparative study with acute myeloid leukemia and aplastic pancytopenias].
    Sánchez Fayos J; Outeiriño Pérez JJ; Prieto E; Román A; Olavarría E; Cabello A; Soto C; Calabuig T; Paniagua C; Sanz B
    Sangre (Barc); 1994 Dec; 39(6):441-8. PubMed ID: 7855696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndromes (MDS) in Central Africans.
    Mukiibi JM; Paul B
    Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.
    Neukirchen J; Schoonen WM; Strupp C; Gattermann N; Aul C; Haas R; Germing U
    Leuk Res; 2011 Dec; 35(12):1591-6. PubMed ID: 21708407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
    Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
    Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes: incidence and survival in the United States.
    Ma X; Does M; Raza A; Mayne ST
    Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
    Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
    J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique.
    Cancer; 1987 Sep; 60(6):1385-94. PubMed ID: 3476180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
    Aul C; Gattermann N; Schneider W
    Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
    Aul C; Gattermann N; Germing U; Runde V; Heyll A
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.
    Hasle H; Kerndrup G; Jacobsen BB
    Leukemia; 1995 Sep; 9(9):1569-72. PubMed ID: 7658725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania.
    Gologan R
    Leuk Res; 2010 Nov; 34(11):1442-6. PubMed ID: 20189246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania.
    Gologan R; Georgescu D; Tatic A; Radulescu I; Vasilache D
    Leuk Res; 2009 Nov; 33(11):1556-61. PubMed ID: 19411107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.